Filtered By:
Therapy: Stem Cell Therapy
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 790 results found since Jan 2013.
Efficacy and Safety of Mesenchymal Stem Cells for COVID-19 Infection: A Meta-Analysis and Systematic Review
CONCLUSIONS: Mesenchymal stem cells can reduce the mortality of COVID-19 patients.PMID:37105930 | DOI:10.24976/Discov.Med.202335175.21
Source: Discovery Medicine - April 27, 2023 Category: Research Authors: Li Chen Qinfei Xu Fen Sheng Beibei Wang Source Type: research
Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe COVID-19 Patients
Curr Stem Cell Res Ther. 2023 Apr 17. doi: 10.2174/1574888X18666230417085117. Online ahead of print.ABSTRACTThe coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), was declared a global pandemic in March 2020 and resulted in more than 6 million deaths worldwide to date. Although several vaccines were produced against COVID-19 and many therapeutic protocols were developed for the management of this respiratory infection, COVID-19 pandemic has still remained an unresolved problem with the emergence of new variants of SARS-CoV-2, especially vaccine-resistant variants. Pro...
Source: Current Stem Cell Research and Therapy - April 19, 2023 Category: Stem Cells Authors: Fezzeh Heidari Mehrdad Nasrollahzadeh Sabet Reza Heidari Amir Ali Hamidieh Zohreh Saltanatpour Source Type: research
Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases
J Autoimmun. 2023 Mar 2;136:103024. doi: 10.1016/j.jaut.2023.103024. Online ahead of print.ABSTRACTHematopoietic stem cell transplant (HSCT) recipients may be at high risk of mortality from coronavirus disease 2019 (COVID-19). However, specific data on COVID-19 after treatment with HSCT in patients affected by autoimmune diseases (ADs) are still lacking. In this multicenter observational study of the European Society for Blood and Marrow Transplantation (EBMT), clinical data on COVID-19 in 11 patients affected by severe ADs treated with HSCT (n = 3 allogeneic transplant; n = 8 autologous transplant) are reported. All patie...
Source: Journal of Autoimmunity - March 31, 2023 Category: Allergy & Immunology Authors: Raffaella Greco John A Snowden Nina Simone Knelange Gloria Tridello Carlotta Cacciatore Alienor Xhaard Fabio Ciceri Matthew Collin Christelle Ferra Ann De Becker Manuela Badoglio Dina Averbuch Tobias Alexander Per Ljungman Rafael De la Camara European Soc Source Type: research
